| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
333,922 |
278,180 |
$14.04M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
38,011 |
32,118 |
$12.31M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
43,859 |
38,051 |
$9.04M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,689 |
10,041 |
$5.92M |
| 59025 |
Fetal non-stress test |
8,605 |
6,502 |
$1.03M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
17,953 |
16,293 |
$884K |
| G0378 |
Hospital observation service, per hour |
6,566 |
1,830 |
$794K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,080 |
4,453 |
$696K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
103,334 |
78,275 |
$593K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,900 |
4,313 |
$446K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
3,126 |
2,891 |
$408K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
5,028 |
4,724 |
$407K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
4,887 |
1,978 |
$399K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
22,527 |
17,012 |
$348K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
4,355 |
3,181 |
$299K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,131 |
2,597 |
$261K |
| 36415 |
Collection of venous blood by venipuncture |
124,121 |
95,097 |
$258K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
69,066 |
50,353 |
$238K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14,208 |
12,224 |
$236K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,270 |
7,576 |
$228K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
10,111 |
8,488 |
$221K |
| 83735 |
|
52,365 |
38,281 |
$216K |
| 84484 |
|
15,743 |
11,627 |
$212K |
| 87536 |
|
13,831 |
10,680 |
$208K |
| 36512 |
|
879 |
575 |
$207K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14,130 |
12,170 |
$196K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,577 |
1,244 |
$185K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,848 |
781 |
$184K |
| 86885 |
|
14,634 |
11,765 |
$176K |
| 80053 |
Comprehensive metabolic panel |
54,105 |
41,487 |
$164K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,853 |
4,949 |
$164K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,167 |
7,429 |
$163K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,532 |
8,235 |
$162K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,874 |
2,261 |
$151K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12,744 |
11,604 |
$147K |
| 86900 |
|
14,790 |
11,889 |
$132K |
| 85027 |
|
36,394 |
28,439 |
$129K |
| 81025 |
|
27,451 |
24,972 |
$128K |
| 90461 |
|
6,756 |
5,830 |
$125K |
| 83605 |
|
16,613 |
13,697 |
$121K |
| 86901 |
|
14,972 |
12,004 |
$118K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,906 |
3,996 |
$110K |
| 84100 |
|
44,311 |
33,051 |
$109K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,635 |
15,811 |
$108K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,631 |
3,868 |
$106K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,096 |
6,964 |
$104K |
| 71045 |
Radiologic examination, chest; single view |
14,041 |
11,064 |
$100K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,494 |
1,215 |
$95K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,388 |
2,005 |
$93K |
| 86360 |
|
7,637 |
6,034 |
$89K |
| Q3014 |
Telehealth originating site facility fee |
6,071 |
5,562 |
$88K |
| 82947 |
|
22,300 |
17,430 |
$88K |
| 86359 |
|
7,686 |
6,071 |
$87K |
| 80076 |
|
28,317 |
21,617 |
$84K |
| 99215 |
Prolong outpt/office vis |
3,380 |
2,881 |
$83K |
| 81003 |
|
43,774 |
37,296 |
$80K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,841 |
2,002 |
$78K |
| 11721 |
|
5,144 |
3,700 |
$76K |
| 76801 |
|
1,153 |
1,069 |
$71K |
| T1015 |
Clinic visit/encounter, all-inclusive |
8,389 |
5,980 |
$68K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,282 |
3,688 |
$65K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,938 |
3,679 |
$60K |
| 87340 |
|
12,205 |
11,109 |
$58K |
| 29581 |
|
2,518 |
779 |
$58K |
| 97597 |
|
1,142 |
717 |
$56K |
| 90686 |
|
6,504 |
4,665 |
$56K |
| 82962 |
|
23,104 |
15,442 |
$51K |
| 86592 |
|
21,038 |
18,198 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,726 |
4,717 |
$50K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,300 |
1,066 |
$48K |
| 96367 |
|
1,683 |
873 |
$47K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,686 |
7,788 |
$45K |
| 80061 |
Lipid panel |
11,701 |
9,221 |
$44K |
| 86803 |
|
6,201 |
5,308 |
$44K |
| 83690 |
|
8,883 |
7,587 |
$41K |
| 86902 |
|
3,460 |
1,786 |
$40K |
| 36430 |
|
1,082 |
723 |
$35K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
486 |
312 |
$33K |
| 73610 |
|
2,313 |
1,840 |
$31K |
| 73552 |
|
1,751 |
1,447 |
$31K |
| 84703 |
|
5,097 |
4,486 |
$31K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
237 |
183 |
$31K |
| 80047 |
|
4,002 |
3,103 |
$28K |
| 76818 |
|
373 |
301 |
$28K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
391 |
336 |
$28K |
| 83880 |
|
2,946 |
2,381 |
$27K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13,640 |
10,683 |
$27K |
| 86920 |
|
1,286 |
624 |
$26K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,414 |
2,853 |
$24K |
| 88184 |
|
6,168 |
4,656 |
$23K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
150 |
121 |
$23K |
| 96160 |
|
1,980 |
1,521 |
$23K |
| 85610 |
|
8,670 |
6,794 |
$23K |
| 73590 |
|
1,707 |
1,401 |
$22K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,548 |
5,834 |
$22K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
251 |
158 |
$22K |
| 11720 |
|
741 |
557 |
$20K |
| 73560 |
|
1,410 |
1,159 |
$20K |
| 76820 |
|
431 |
270 |
$19K |
| 76821 |
|
422 |
254 |
$18K |
| 81001 |
|
17,642 |
14,747 |
$18K |
| 85018 |
|
6,772 |
5,405 |
$17K |
| 82728 |
|
7,672 |
5,535 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
596 |
493 |
$17K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
123 |
81 |
$17K |
| 92550 |
|
878 |
812 |
$17K |
| 72190 |
|
886 |
828 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
611 |
406 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
2,960 |
2,515 |
$16K |
| 88185 |
|
6,191 |
4,656 |
$15K |
| 83020 |
|
4,416 |
2,869 |
$15K |
| 85660 |
|
4,908 |
2,324 |
$15K |
| 84702 |
|
939 |
828 |
$15K |
| 86762 |
|
2,300 |
2,104 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,340 |
1,774 |
$14K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
630 |
159 |
$13K |
| 86480 |
|
1,109 |
919 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
608 |
365 |
$13K |
| 90715 |
|
488 |
454 |
$13K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
55 |
36 |
$12K |
| 52000 |
|
47 |
38 |
$12K |
| 11056 |
|
1,669 |
1,169 |
$12K |
| 70496 |
|
114 |
95 |
$12K |
| 70498 |
|
114 |
95 |
$12K |
| 85014 |
|
7,412 |
5,411 |
$12K |
| 86922 |
|
1,430 |
656 |
$11K |
| 82565 |
|
2,471 |
2,060 |
$10K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,106 |
882 |
$9K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
42 |
40 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
227 |
194 |
$8K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
38 |
29 |
$8K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
305 |
197 |
$8K |
| 85730 |
|
1,421 |
1,196 |
$8K |
| 87081 |
|
1,910 |
1,767 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,318 |
1,748 |
$7K |
| 73630 |
|
596 |
388 |
$7K |
| 85045 |
|
6,590 |
4,686 |
$7K |
| 82550 |
|
1,269 |
959 |
$6K |
| 90670 |
|
177 |
126 |
$6K |
| 86140 |
|
4,043 |
3,348 |
$6K |
| 87210 |
|
1,501 |
1,392 |
$6K |
| 83550 |
|
3,799 |
2,887 |
$6K |
| 90677 |
|
54 |
40 |
$5K |
| 73130 |
|
416 |
234 |
$5K |
| 51798 |
|
129 |
111 |
$5K |
| 76827 |
|
120 |
97 |
$5K |
| 99201 |
|
349 |
337 |
$5K |
| 82570 |
|
1,251 |
1,047 |
$5K |
| G0008 |
Administration of influenza virus vaccine |
2,232 |
1,592 |
$5K |
| 99205 |
Prolong outpt/office vis |
71 |
63 |
$5K |
| 76770 |
|
122 |
107 |
$5K |
| 11719 |
|
291 |
225 |
$5K |
| 87077 |
|
958 |
882 |
$5K |
| 94760 |
|
592 |
498 |
$4K |
| 83540 |
|
3,807 |
2,895 |
$4K |
| 92551 |
|
428 |
372 |
$4K |
| 83970 |
|
669 |
532 |
$4K |
| 96127 |
|
840 |
758 |
$4K |
| 73562 |
|
478 |
290 |
$4K |
| 36416 |
|
1,528 |
1,306 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
60 |
55 |
$4K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,411 |
1,657 |
$4K |
| 99195 |
|
616 |
385 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
398 |
342 |
$3K |
| 97802 |
|
63 |
50 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$3K |
| 84153 |
|
1,585 |
1,288 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,128 |
9,244 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
72 |
68 |
$3K |
| 95115 |
|
163 |
151 |
$3K |
| 86706 |
|
1,038 |
868 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,834 |
1,939 |
$3K |
| 51702 |
|
29 |
25 |
$3K |
| 86704 |
|
830 |
691 |
$3K |
| 76830 |
Ultrasound, transvaginal |
44 |
41 |
$2K |
| 74178 |
|
14 |
12 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
311 |
267 |
$2K |
| 96417 |
|
56 |
25 |
$2K |
| 17110 |
|
16 |
16 |
$2K |
| 94726 |
|
87 |
72 |
$2K |
| 90656 |
|
181 |
158 |
$2K |
| 20610 |
|
17 |
14 |
$2K |
| 83615 |
|
914 |
713 |
$2K |
| 82378 |
|
1,049 |
743 |
$2K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
17 |
16 |
$2K |
| 87522 |
Neg quan hep c or qual rna |
192 |
172 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
16 |
14 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
320 |
94 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,701 |
7,377 |
$2K |
| 93325 |
|
83 |
67 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,139 |
6,557 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,429 |
963 |
$2K |
| 81000 |
|
347 |
319 |
$1K |
| 99173 |
|
2,910 |
2,650 |
$1K |
| 94729 |
|
87 |
72 |
$1K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
19 |
12 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
347 |
334 |
$1K |
| 73110 |
|
75 |
66 |
$1K |
| 72110 |
|
75 |
59 |
$1K |
| 85004 |
|
748 |
651 |
$1K |
| 96161 |
|
187 |
167 |
$1K |
| 73120 |
|
82 |
38 |
$1K |
| 84439 |
|
576 |
488 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,003 |
3,972 |
$1K |
| 84154 |
|
145 |
125 |
$1K |
| 97602 |
|
45 |
24 |
$1K |
| 90734 |
|
83 |
74 |
$1K |
| 82948 |
|
708 |
552 |
$1K |
| 85652 |
|
559 |
484 |
$1K |
| 82677 |
|
60 |
58 |
$980.12 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
18 |
18 |
$959.39 |
| 90694 |
|
338 |
207 |
$900.58 |
| 82397 |
|
569 |
422 |
$850.34 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
3,575 |
3,217 |
$839.17 |
| 93017 |
|
16 |
13 |
$805.22 |
| 84156 |
|
1,222 |
1,031 |
$802.34 |
| 82105 |
|
94 |
89 |
$780.19 |
| 36591 |
|
304 |
261 |
$624.08 |
| 87529 |
|
40 |
37 |
$614.03 |
| 93926 |
|
15 |
12 |
$580.34 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
81 |
79 |
$559.88 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
12 |
12 |
$546.28 |
| 84144 |
|
25 |
24 |
$506.69 |
| 83516 |
|
196 |
162 |
$504.86 |
| 82607 |
|
168 |
122 |
$502.76 |
| 73620 |
|
26 |
12 |
$500.42 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
12 |
12 |
$458.14 |
| 85378 |
|
62 |
52 |
$436.92 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
55 |
51 |
$434.49 |
| 81002 |
|
222 |
211 |
$398.48 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31 |
28 |
$396.40 |
| 86708 |
|
201 |
159 |
$386.77 |
| 87040 |
|
20 |
14 |
$386.05 |
| 73090 |
|
38 |
36 |
$378.20 |
| 90732 |
|
39 |
30 |
$365.79 |
| 87430 |
|
20 |
20 |
$351.40 |
| 82784 |
|
137 |
90 |
$348.84 |
| 94060 |
|
15 |
12 |
$348.79 |
| 84550 |
|
121 |
102 |
$345.94 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
1,486 |
494 |
$344.69 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
211 |
156 |
$332.54 |
| 82465 |
|
427 |
352 |
$322.33 |
| 84155 |
|
296 |
196 |
$315.74 |
| 80069 |
|
234 |
192 |
$313.80 |
| 82310 |
|
856 |
568 |
$308.95 |
| 82040 |
|
855 |
567 |
$307.89 |
| 85007 |
|
371 |
278 |
$300.56 |
| 73030 |
|
31 |
28 |
$298.84 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
584 |
438 |
$287.52 |
| 86431 |
|
174 |
146 |
$229.33 |
| 90634 |
|
74 |
50 |
$227.80 |
| 82803 |
|
19 |
13 |
$221.04 |
| 73060 |
|
12 |
12 |
$211.88 |
| 84480 |
|
83 |
56 |
$208.63 |
| 90700 |
|
12 |
12 |
$208.16 |
| 90723 |
|
29 |
26 |
$201.90 |
| 84165 |
|
271 |
178 |
$201.60 |
| 90633 |
|
12 |
12 |
$197.00 |
| 92511 |
|
43 |
18 |
$185.52 |
| 83883 |
|
75 |
50 |
$170.04 |
| 85379 |
|
17 |
15 |
$150.60 |
| 86300 |
|
87 |
66 |
$130.14 |
| 72170 |
|
12 |
12 |
$116.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
966 |
824 |
$113.54 |
| 90714 |
|
29 |
25 |
$111.75 |
| 82330 |
|
17 |
12 |
$109.44 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
210 |
164 |
$105.35 |
| 84436 |
|
83 |
56 |
$99.40 |
| 86320 |
|
34 |
25 |
$93.48 |
| 84479 |
|
83 |
56 |
$91.90 |
| 90648 |
|
109 |
82 |
$88.28 |
| 90658 |
|
52 |
47 |
$84.64 |
| 87186 |
|
100 |
88 |
$81.09 |
| 73502 |
|
18 |
12 |
$75.52 |
| 83718 |
|
69 |
48 |
$68.24 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
35 |
27 |
$66.69 |
| 74019 |
|
12 |
12 |
$55.22 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
626 |
445 |
$51.20 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
526 |
370 |
$47.85 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
29 |
26 |
$44.99 |
| J3490 |
Unclassified drugs |
505 |
324 |
$42.81 |
| 86705 |
|
20 |
16 |
$36.78 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
12 |
$35.92 |
| 86709 |
|
20 |
17 |
$35.19 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
84 |
38 |
$34.88 |
| 82044 |
|
20 |
16 |
$34.46 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
478 |
352 |
$32.14 |
| 82746 |
|
22 |
15 |
$30.64 |
| 85048 |
|
74 |
40 |
$15.90 |
| J2704 |
Injection, propofol, 10 mg |
1,779 |
1,369 |
$9.88 |
| J1644 |
Injection, heparin sodium, per 1000 units |
81 |
24 |
$9.68 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
199 |
142 |
$3.89 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,547 |
1,183 |
$2.24 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
246 |
176 |
$1.80 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
33 |
25 |
$1.16 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
79 |
61 |
$1.04 |
| 96376 |
|
31 |
14 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
85 |
63 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
70 |
49 |
$0.00 |
| 90716 |
|
35 |
27 |
$0.00 |
| 90698 |
|
21 |
19 |
$0.00 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
22 |
12 |
$0.00 |
| 90680 |
|
43 |
39 |
$0.00 |
| 80320 |
|
18 |
15 |
$0.00 |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
20 |
13 |
$0.00 |
| 36514 |
|
21 |
14 |
$0.00 |
| 90657 |
|
13 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
42 |
39 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
20 |
17 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
46 |
39 |
$0.00 |
| 90707 |
|
16 |
16 |
$0.00 |
| 99152 |
|
15 |
13 |
$0.00 |